Revised guideline to assess risk of human medicines for the environment

November 30, 2018 – EMA has published a revision of its guideline on the environmental risk assessment (ERA) of human medicines for a six-month public consultation. Stakeholders are invited to send their comments by 30 June 2019 to era_dg@ema.europa.eu using the Microsoft Office document template provided. The presence of biologically-active pharmaceuticals in the environment is a growing concern, because some of these substances have … (leggi tutto)